Main competitors
Dividend Yield (Y) Dividend Yield (Y+1) P/E (Y) Price to Book (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Capi.($)
-.--%-.--%15.91x1.36x2.94x8.55x9.46x 27.74B
0.52%0.6%19.11x2.32x4.41x12.53x13.56x 77.47B
2.55%2.76%23.1x2.9x4.19x12.18x14.06x 58.42B
0.54%0.55%42.46x4.69x6.67x21.18x29.05x 59.92B
-.--%-.--%51.52x6.93x13.6x29.17x36.53x 54.39B
-.--%-.--%16.03x3.4x3.14x9.39x9.56x 19.64B
-.--%0.07%81.48x7.88x9.71x90.42x97.22x 19.9B
-.--%-.--%-5.32x1.91x6.16x-3.7x-3.51x 16.41B
-.--%-.--%672.8x3.48x5.24x13.39x42.24x 15.54B
-.--%-.--%-21.08x-6.88x30.47x-30.9x-30.03x 13.97B
-.--%-.--%24.02x - 3.21x16.48x16.21x 11.46B
-.--%-.--%-16.27x - 585.81x-15.97x-16.19x 10.98B
-.--%-.--%-48.71x202.01x14.4x-57.9x-53.64x 9.29B
1.43%1.71%18x1.2x2.08x8.62x11.46x 8.11B
-.--%-.--%39.73x - 18.94x44.53x45.64x 7.85B
-.--%-.--%-229.54x - - - - 7.59B
3.66%2.29%5.53x2.15x2.4x3.58x3.63x 7.83B
Average 0.51% 0.47% 40.52x 17.95x 44.59x 10.10x 14.08x 25.09B
Weighted average by Cap. 0.61% 0.64% 44.61x 8.13x 22.58x 15.27x 19.46x
Biopharmaceuticals